Aging Delay: of Mice and Men

Overview

Journal Acta Biomed

Specialty General Medicine

Date 2021 Mar 8

PMID 33682799

Authors

Vladimir Anisimov

Affiliations

Soon will be listed here.

Abstract

The evaluation of the safety of a drug in rodents that may be used as geroprotectors is a challenge of current times. In the paper, we discuss approaches to long-term assays for selection of potent aging delay drugs for humans. Priority is given to methods combining evaluation of carcinogenic safety and life-spanning potential. The use of such methods will be time-efficient and economically feasible.

References

Anisimov V . Metformin for cancer and aging prevention: is it a time to make the long story short?. Oncotarget. 2015; 6(37):39398-407. PMC: 4741834. DOI: 10.18632/oncotarget.6347. View

Anisimov V, Sidorenko A . It is necessary to establish an International Agency for Research on Aging. Aging (Albany NY). 2018; 10(5):863-867. PMC: 5990390. DOI: 10.18632/aging.101451. View

Anisimov V, Popovich I, Zabezhinski M, Anisimov S, Vesnushkin G, Vinogradova I . Melatonin as antioxidant, geroprotector and anticarcinogen. Biochim Biophys Acta. 2006; 1757(5-6):573-89. DOI: 10.1016/j.bbabio.2006.03.012. View

Nadon N, Strong R, Miller R, Harrison D . NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse Model. EBioMedicine. 2016; 21:3-4. PMC: 5514387. DOI: 10.1016/j.ebiom.2016.11.038. View

Anisimov V, Popovich I, Zabezhinski M . Methods of testing pharmacological drugs effects on aging and life span in mice. Methods Mol Biol. 2013; 1048:145-60. DOI: 10.1007/978-1-62703-556-9_12. View

Neff F, Flores-Dominguez D, Ryan D, Horsch M, Schroder S, Adler T . Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest. 2013; 123(8):3272-91. PMC: 3726163. DOI: 10.1172/JCI67674. View

Kennedy B, Partridge L . 2nd interventions in aging conference. Aging (Albany NY). 2017; 9(4):1090-1095. PMC: 5425116. DOI: 10.18632/aging.101221. View

Anisimov V . Premature ageing prevention: limitations and perspectives of pharmacological interventions. Curr Drug Targets. 2006; 7(11):1485-503. DOI: 10.2174/1389450110607011485. View

Longo V, Antebi A, Bartke A, Barzilai N, Brown-Borg H, Caruso C . Interventions to Slow Aging in Humans: Are We Ready?. Aging Cell. 2015; 14(4):497-510. PMC: 4531065. DOI: 10.1111/acel.12338. View

10.

Aliper A, Belikov A, Garazha A, Jellen L, Artemov A, Suntsova M . In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state. Aging (Albany NY). 2016; 8(9):2127-2152. PMC: 5076455. DOI: 10.18632/aging.101047. View

11.

Anisimov V, Ukraintseva S, Yashin A . Cancer in rodents: does it tell us about cancer in humans?. Nat Rev Cancer. 2005; 5(10):807-19. DOI: 10.1038/nrc1715. View

12.

Spindler S . Review of the literature and suggestions for the design of rodent survival studies for the identification of compounds that increase health and life span. Age (Dordr). 2011; 34(1):111-20. PMC: 3260350. DOI: 10.1007/s11357-011-9224-6. View

13.

Blagosklonny M . Koschei the immortal and anti-aging drugs. Cell Death Dis. 2014; 5:e1552. PMC: 4649836. DOI: 10.1038/cddis.2014.520. View

14.

Anisimov V . Life span extension and cancer risk: myths and reality. Exp Gerontol. 2001; 36(7):1101-36. DOI: 10.1016/s0531-5565(01)00114-0. View

15.

Vaiserman A, Lushchak O, Koliada A . Anti-aging pharmacology: Promises and pitfalls. Ageing Res Rev. 2016; 31:9-35. DOI: 10.1016/j.arr.2016.08.004. View

16.

Kennedy B, Pennypacker J . Aging interventions get human. Oncotarget. 2015; 6(2):590-1. PMC: 4359240. DOI: 10.18632/oncotarget.3173. View

17.

Anisimov V, Zabezhinski M, Popovich I, Pliss G, Bespalov V, Alexandrov V . Rodent models for the preclinical evaluation of drugs suitable for pharmacological intervention in aging. Expert Opin Drug Discov. 2012; 7(1):85-95. DOI: 10.1517/17460441.2012.642361. View